Profile data is unavailable for this security.
About the company
Allmed Solutions Ltd, former Allium Medical Solutions Ltd, is an Israel-based company, which develops, manufactures and markets minimally invasive products internationally. Its products are used by physicians to treat a number of diseases and patients worldwide. The Company's product lines include: Covered Stents, which offers Ureteral Stent (URS), Round Posterior Stent (RPS), Triangular Prostatic Stent (TPS), Bulbar Stent (BUS) and Biliary Stent (BIS); Uro-Gynecology, which offers EndoFast Reliant System, EndoFast Resorb, EndoFast Reliant MN and EndoFast Reliant SCP; Type II Diabetes, which offers the Gastro-duodenal sleeve (GDS), as well as Cardiovascular, which offers WIRION EPD System. The Company's products serve patients with the following medical conditions: Pelvic Organ Prolapse (POP), Sacrocolpopexy, Male Stress Urinary Incontinence (SUI), Urethral/Ureteral Stricture, Carotid Stenosis, Biliary Stricture and Type II Diabetes.
- Revenue in ILS (TTM)0.00
- Net income in ILS-13.57m
- Incorporated2004
- Employees19.00
- LocationAllmed Solutions LtdHailan 12CAESAREA 3063908IsraelISR
- Phone+972 466277166
- Fax+972 46277266
- Websitehttps://www.allium-medical.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sonovia Ltd | 0.00 | -14.31m | 10.55m | 28.00 | -- | 0.5242 | -- | -- | -0.8716 | -0.8227 | 0.00 | 1.22 | 0.00 | -- | -- | 0.00 | -49.13 | -32.92 | -52.57 | -39.48 | -- | -- | -- | -- | -- | -- | 0.0015 | -- | -- | -- | 50.27 | -- | -- | -- |
| Human Xtensions Ltd | 2.53m | -29.31m | 13.35m | 50.00 | -- | 1.03 | -- | 5.29 | -1.10 | -1.10 | 0.0947 | 0.4824 | 0.0694 | 0.2452 | 0.8885 | 50,500.00 | -80.53 | -49.34 | -95.39 | -55.69 | 57.62 | 49.34 | -1,160.87 | -485.43 | 3.01 | -- | 0.073 | -- | 56.00 | -- | 17.84 | -- | -19.95 | -- |
| Elbit Medical Technologies Ltd | 2.97m | -56.43m | 16.87m | 232.00 | -- | 0.5791 | -- | 5.67 | -0.622 | -0.622 | 0.0328 | 0.321 | 0.0512 | -- | 40.05 | -- | -97.15 | 37.04 | -98.41 | 38.19 | 94.62 | -- | -1,898.59 | 41.14 | -- | 0.0162 | 0.00 | -- | 314.29 | -55.19 | -248.15 | -- | -- | -- |
| BioLight Life Sciences Ltd | 198.00k | -6.16m | 19.75m | 4.00 | -- | 0.6326 | -- | 99.77 | -1.32 | -1.32 | 0.0427 | 6.70 | 0.0052 | -- | 0.3257 | 49,500.00 | -19.06 | -20.22 | -20.83 | -21.13 | -- | -- | -3,689.39 | -12,746.09 | -- | -- | 0.0263 | -- | 87.30 | -49.76 | -231.59 | -- | 92.16 | -- |
| Erika B-Cure Laser Ltd | 32.88m | -9.85m | 28.21m | -- | -- | 1.17 | -- | 0.8582 | -0.0951 | -0.0951 | 0.3164 | 0.2315 | 0.7015 | 0.4885 | 4.56 | -- | -21.03 | -- | -30.65 | -- | 75.96 | 87.63 | -29.97 | -14.48 | 1.09 | -- | 0.1323 | -- | -40.62 | -3.40 | 40.97 | -- | -19.27 | -- |
| Endymed Ltd | 74.60m | -3.18m | 30.76m | 46.00 | -- | 0.551 | -- | 0.4123 | -0.2315 | -0.2315 | 5.47 | 4.06 | 0.9557 | 1.84 | 10.16 | 1,621,805.00 | -4.07 | 10.38 | -5.09 | 13.32 | 49.68 | 51.92 | -4.26 | 8.91 | 2.75 | -- | 0.0723 | -- | 6.77 | 4.30 | -34.94 | -22.83 | -15.24 | -- |
| Bio-View Ltd | 34.34m | 887.00k | 35.61m | -- | 43.27 | 1.16 | 12.96 | 1.04 | 0.0062 | 0.0062 | 0.2467 | 0.2335 | 0.806 | 1.76 | 4.75 | -- | 2.08 | 3.45 | 2.80 | 4.57 | 64.86 | 58.71 | 2.58 | 4.20 | 2.17 | -- | 0.0874 | -- | 19.29 | 6.58 | -34.75 | -- | 8.77 | -- |
| Allmed Solutions Ltd | 0.00 | -13.57m | 38.56m | 19.00 | -- | 0.8616 | -- | -- | -0.1218 | -0.1218 | 0.00 | 0.4643 | 0.00 | -- | -- | 0.00 | -22.76 | 1.43 | -24.91 | 1.59 | -- | 50.43 | -- | 15.58 | -- | -- | 0.015 | -- | -- | -- | 111.71 | -- | -10.48 | -- |
| Nissan Medical Industries Ltd. | 729.00m | 19.45m | 127.99m | 395.00 | 6.74 | 0.5174 | 1.86 | 0.1756 | 2.09 | 2.09 | 78.18 | 27.23 | 0.9928 | 4.96 | 6.62 | 1,845,565.00 | 5.24 | 4.12 | 10.16 | 7.71 | 20.04 | 18.76 | 5.28 | 4.32 | 0.5598 | 3.15 | 0.3279 | -- | 7.20 | 2.20 | 115.67 | -25.79 | -3.21 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Ayalon Mutual Funds Ltd.as of 30 Apr 2024 | 1.43m | 1.49% |
| Psagot Mutual Funds Ltd.as of 30 Apr 2024 | 126.00k | 0.13% |
